Pay in 4 interest-free payments of $7.46 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
NEWS Correction 30 June 2025 Obesity drugs made in China could power next wave of treatments Access options Access Nature and 54 other Nature Portfolio journals Get Nature+, our best-value online-access subscription $32.99 / 30 days cancel any time Subscribe to this journal Receive 52 print issues and online access $199.00 per year only $3.83 per issue Rent or buy this article Prices vary by article type from$1.95 to$39.95 Prices may be subject to local taxes which are calculated during checkout Nature 643 , 315-316 (2025) doi: Updates & Corrections Correction 30 June 2025 : An earlier version of this story misnamed the US Food and Drug Administration
These effects occur at the expense of a slight increase in hypoglycemia, but careful titration of insulin doses may mitigate this risk
Van Gaal, I
$249.00 USD Frequently Asked Questions Semaglutide and Tirzepatide Certification Course
The improvements came not just from additional weight loss but from better overall metabolic markers and reduced side effect burden
